
Emily Ann Cordas
Examiner (ID: 8282, Phone: (571)272-2905 , Office: P/1651 )
| Most Active Art Unit | 1632 |
| Art Unit(s) | 1632, 1651 |
| Total Applications | 642 |
| Issued Applications | 272 |
| Pending Applications | 121 |
| Abandoned Applications | 287 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17814224
[patent_doc_number] => 11419811
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-23
[patent_title] => Means and methods for preventing and/or treating caries
[patent_app_type] => utility
[patent_app_number] => 16/580658
[patent_app_country] => US
[patent_app_date] => 2019-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22701
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 186
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16580658
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/580658 | Means and methods for preventing and/or treating caries | Sep 23, 2019 | Issued |
Array
(
[id] => 16523742
[patent_doc_number] => 20200397822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => PERSONALIZED TUMOR ANTIGEN SPECIFIC T CELL LINES FOR CANCER TREATMENT
[patent_app_type] => utility
[patent_app_number] => 16/576725
[patent_app_country] => US
[patent_app_date] => 2019-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16576725
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/576725 | PERSONALIZED TUMOR ANTIGEN SPECIFIC T CELL LINES FOR CANCER TREATMENT | Sep 18, 2019 | Abandoned |
Array
(
[id] => 15263191
[patent_doc_number] => 20190380329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => PERFUSION DEVICE AND PERFUSION METHOD
[patent_app_type] => utility
[patent_app_number] => 16/552519
[patent_app_country] => US
[patent_app_date] => 2019-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15521
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16552519
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/552519 | PERFUSION DEVICE AND PERFUSION METHOD | Aug 26, 2019 | Abandoned |
Array
(
[id] => 15239787
[patent_doc_number] => 20190374679
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => METHOD FOR PREPARING AN ANIMAL DECELLULARIZED TISSUE MATRIX MATERIAL AND A DECELLULARIZED TISSUE MATRIX MATERIAL PREPARED THEREBY
[patent_app_type] => utility
[patent_app_number] => 16/545338
[patent_app_country] => US
[patent_app_date] => 2019-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10544
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 535
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16545338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/545338 | Method for preparing an animal decellularized tissue matrix material and a decellularized tissue matrix material prepared thereby | Aug 19, 2019 | Issued |
Array
(
[id] => 15496827
[patent_doc_number] => 20200048602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-13
[patent_title] => METHOD AND SYSTEM FOR PRINTING CELLS TO A SUBSTRATE COMPRISING CELL ADHESIVE REGIONS
[patent_app_type] => utility
[patent_app_number] => 16/534624
[patent_app_country] => US
[patent_app_date] => 2019-08-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16534624
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/534624 | Method and system for printing cells to a substrate comprising cell adhesive regions | Aug 6, 2019 | Issued |
Array
(
[id] => 15239783
[patent_doc_number] => 20190374677
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => MODIFIED SURFACES FOR ATTACHMENT OF BIOLOGICAL MATERIALS
[patent_app_type] => utility
[patent_app_number] => 16/532545
[patent_app_country] => US
[patent_app_date] => 2019-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16532545
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/532545 | MODIFIED SURFACES FOR ATTACHMENT OF BIOLOGICAL MATERIALS | Aug 5, 2019 | Abandoned |
Array
(
[id] => 17082387
[patent_doc_number] => 20210277393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-09
[patent_title] => CIRCULARIZED ENGINEERED RNA AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/261825
[patent_app_country] => US
[patent_app_date] => 2019-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17261825
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/261825 | CIRCULARIZED ENGINEERED RNA AND METHODS | Jul 23, 2019 | Pending |
Array
(
[id] => 17140315
[patent_doc_number] => 20210308326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => IMPLANTS TO INDUCE BONE REGENERATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/260754
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260754 | IMPLANTS TO INDUCE BONE REGENERATION AND USES THEREOF | Jul 17, 2019 | Pending |
Array
(
[id] => 17140315
[patent_doc_number] => 20210308326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => IMPLANTS TO INDUCE BONE REGENERATION AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/260754
[patent_app_country] => US
[patent_app_date] => 2019-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16260
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17260754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/260754 | IMPLANTS TO INDUCE BONE REGENERATION AND USES THEREOF | Jul 17, 2019 | Pending |
Array
(
[id] => 19777472
[patent_doc_number] => 12226493
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-02-18
[patent_title] => Methods of treating non-syndromic sensorineural hearing loss
[patent_app_type] => utility
[patent_app_number] => 17/259661
[patent_app_country] => US
[patent_app_date] => 2019-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 18
[patent_no_of_words] => 60430
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17259661
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/259661 | Methods of treating non-syndromic sensorineural hearing loss | Jul 11, 2019 | Issued |
Array
(
[id] => 16570953
[patent_doc_number] => 20210009959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => METHODS FOR ENHANCING OSTEOGENIC DIFFERENTIATION USING VITAMIN D
[patent_app_type] => utility
[patent_app_number] => 16/507174
[patent_app_country] => US
[patent_app_date] => 2019-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16507174
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/507174 | METHODS FOR ENHANCING OSTEOGENIC DIFFERENTIATION USING VITAMIN D | Jul 9, 2019 | Abandoned |
Array
(
[id] => 15039181
[patent_doc_number] => 20190330595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => MAMMALIAN CELLS ENRICHED WITH FUNCTIONAL MITOCHONDRIA
[patent_app_type] => utility
[patent_app_number] => 16/445680
[patent_app_country] => US
[patent_app_date] => 2019-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16445680
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/445680 | Mammalian cells enriched with functional mitochondria | Jun 18, 2019 | Issued |
Array
(
[id] => 15210385
[patent_doc_number] => 20190367879
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => COMPOSITION FOR ENHANCING HAIR GROWTH-INDUCING ABILITY OF ADIPOSE STEM CELLS COMPRISING UDENAFIL AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/427084
[patent_app_country] => US
[patent_app_date] => 2019-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427084
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427084 | Composition for enhancing hair growth-inducing ability of adipose stem cells comprising udenafil as active ingredient | May 29, 2019 | Issued |
Array
(
[id] => 16946538
[patent_doc_number] => 20210205229
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => MICROENCAPSULATED MODIFIED POLYNUCLEOTIDE COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/056648
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12586
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056648 | MICROENCAPSULATED MODIFIED POLYNUCLEOTIDE COMPOSITIONS AND METHODS | May 22, 2019 | Abandoned |
Array
(
[id] => 17378304
[patent_doc_number] => 11236302
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-01
[patent_title] => Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases
[patent_app_type] => utility
[patent_app_number] => 16/414848
[patent_app_country] => US
[patent_app_date] => 2019-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 52
[patent_no_of_words] => 17566
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 207
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16414848
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/414848 | Methods and compositions for producing stem cell derived dopaminergic cells for use in treatment of neurodegenerative diseases | May 16, 2019 | Issued |
Array
(
[id] => 14806309
[patent_doc_number] => 20190269764
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => POWDER FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/408678
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16408678
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/408678 | POWDER FORMULATION | May 9, 2019 | Abandoned |
Array
(
[id] => 17156352
[patent_doc_number] => 20210317403
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-14
[patent_title] => STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/053422
[patent_app_country] => US
[patent_app_date] => 2019-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13621
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 191
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053422
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/053422 | STEM CELL-DERIVED CELL CULTURES, STEM CELL-DERIVED THREE DIMENSIONAL TISSUE PRODUCTS, AND METHODS OF MAKING AND USING THE SAME | May 8, 2019 | Pending |
Array
(
[id] => 18153255
[patent_doc_number] => 11566220
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-01-31
[patent_title] => Cell line consecutively expressing HLA-G protein and method for preparing the same
[patent_app_type] => utility
[patent_app_number] => 16/486882
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 11295
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 359
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16486882
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/486882 | Cell line consecutively expressing HLA-G protein and method for preparing the same | Apr 25, 2019 | Issued |
Array
(
[id] => 17200478
[patent_doc_number] => 20210340573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-04
[patent_title] => RAPAMYCIN RESISTANT CELLS
[patent_app_type] => utility
[patent_app_number] => 17/049782
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50441
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049782
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049782 | Rapamycin resistant cells | Apr 24, 2019 | Issued |
Array
(
[id] => 14780653
[patent_doc_number] => 20190265224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-29
[patent_title] => METHOD FOR RAPID TESTING ALLERGY
[patent_app_type] => utility
[patent_app_number] => 16/393579
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13072
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393579
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/393579 | Method for rapid testing allergy | Apr 23, 2019 | Issued |